Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Paul Engstrom

Center AffiliationsCancer Prevention and Control

Publications (136) (print view)

no pagination
Engstrom PF, Sigurdson E, Evans AA, Pingpank JF. Primary neoplams of the liver. In: Kufe DW, Pollock RE, editors. Cancer medicine. Hamilton, Ontario ; New York: B.C. Decker; 2003. p. 1542-53.
Fang CY, Miller SM, Malick J, Babb J, Engstrom PF, Daly MB. Psychosocial correlates of intention to undergo prophylactic oophorectomy among women with a family history of ovarian cancer. Prev Med. 2003 Nov;37(5):424-31.
Schnoll RA, Zhang B, Rue M, Krook JE, Spears WT, Marcus AC, Engstrom PF. Brief physician-initiated quit-smoking strategies for clinical oncology settings: a trial coordinated by the eastern cooperative oncology group. Journal of Clinical Oncology. 2003 Jan;21(2):355-65.
Uzzo RG, Watkins-Bruner D, Horwitz EM, Konski A, Pollack A, Engstrom PF, Kolenko V. Prostate cancer prevention: strategies and realities. In: Mydlo JH, Godec CJ, editors. Prostate cancer : science and clinical practice. Amsterdam ; San Diego: Academic Press; 2003. p. 89-99.
Cornfeld MJ, Schnoll RA, Tofani SH, Babb JS, Miller SM, Henigan-Peel T, Balshem A, Slater E, Ross E, Siemers S, Montgomery S, Malstrom M, Hunt P, Boyd S, Engstrom PF. Implementation of a comprehensive cancer control program at the worksite: year one summary report. J Occup Environ Med. 2002 May;44(5):398-406.
Diefenbach MA, Dorsey J, Uzzo RG, Hanks GE, Greenberg RE, Horwitz E, Newton F, Engstrom PF. Decision-making strategies for patients with localized prostate cancer. Semin Urol Oncol. 2002 Feb;20(1):55-62.
Lewis NL, Scher R, Gallo JM, Engstrom PF, Szarka CE, Litwin S, Adams AL, Kilpatrick D, Brady D, Weiner LM, Meropol NJ. Phase I and pharmacokinetic study of irinotecan in combination with raltitrexed. Cancer Chemotherapy and Pharmacology. 2002 Oct;50(4):257-65.
Cornfeld MJ, Jadwin A, O'Grady P, Babb J, Engstrom PF. Feasibility of assessing quality in medical oncology practices. Cancer Pract. 2001 Sep;9(5):231-5.
Jadwin A, O'Grady P, Babb J, Engstrom PF. Feasibility of assessing quality in medical oncology practices. Cancer Practice. 2001 Jan;9(5):231-5.
Miller SM, Diefenbach MA, Kruus LK, Watkins-Bruner D, Hanks GE, Engstrom PF. Psychological and screening profiles of first-degree relatives of prostate cancer patients. J Behav Med. 2001 Jun;24(3):247-58.
Szarka CE, Yao KS, Pfeiffer GR, Balshem AM, Litwin S, Frucht H, Goosenberg EB, Engstrom PF, Clapper ML, O'Dwyer PJ. Chronic dosing of oltipraz in people at increased risk for colorectal cancer. Cancer Detect Prev. 2001 Jan;25(4):352-61.
Engstrom PF, Benson A, Choti MA, Cohen AM, Doroshow JH, Fuchs C, Kiel K, Martin EW, McGinn C, Petrelli NJ, Posey JA, Skibber JM, Venook A, Yeatman TJ. NCCN Practice Guidelines for colorectal cancer. Oncology-New York. 2000 Nov;14(11A):203-12.
Engstrom PF, Clapper M, Schnoll RA, Orleans CT. Prevention of tobacco-related cancers. In: Bast RC, Kufe DW, Pollock RE, Weichselbaum RR, Holland JF, Frei E, Gansler TS, American Cancer Society, editors. Cancer medicine. Hamilton, Ontario ; New York: B.C. Decker; 2000. p. 314-27.
Engstrom PF, Sigurdson E, Evans AA. Cancer medicine. In: Bast RC, Kufe DW, Holland JF, editors. Primary neoplasms of the liver. Hamilton, Ontario ; New York: B.C. Decker; 2000. p. 1391-401.
Higman SA, McKay FJ, Engstrom PF, O'Grady MA, Young RC. Fox Chase Network: Fox Chase Cancer Center's community hospital affiliation program. The oncologist. 2000 Jan;5(4):329-35.
Simunovic M, To T, Baxter N, Balshem A, Ross E, Cohen Z, McLeod R, Engstrom P, Sigurdson E. Hospital procedure volume and teaching status do not influence treatment and outcome measures of rectal cancer surgery in a large general population. J Gastrointest Surg. 2000 May;4(3):324-30.
Bruner DW, Baffoe-Bonnie A, Miller S, Diefenbach M, Tricoli JV, Daly M, Pinover W, Grumet SC, Stofey J, Ross E, Raysor S, Balshem A, Malick J, Engstrom P, Hanks GE, Mirchandani I. Prostate cancer risk assessment program. A model for the early detection of prostate cancer. Oncology (Huntingt). 1999 Mar;13(3):325-34; discussion 337-9, 343-4 pas.
Engstrom PF. A new era for cancer prevention and control research. Cancer Epidemiology Biomarkers & Prevention. 1999 Nov;8(11):955-6.
Garay CA, Engstrom PF. Chemoprevention of colorectal cancer: Dietary and pharmacologic approaches. Oncology-New York. 1999 Jan;13(1):89-97.
Liu SC, Hu Y, Sauter ER, Clapper ML, Chen SY, Lanfranchi HE, Engstrom PF, Klein-Szanto AJ. Image analysis of p53 and cyclin D1 expression in premalignant lesions of the oral mucosa. Analytical and Quantitative Cytology and Histology. 1999 Apr;21(2):166-73.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

Paul Engstrom Sparkline Graph

Graph Interactions


Similar Investigators:

Keywords (MeSH):

Last updated on Friday, December 06, 2019